SE9901578D0 - New use of substance in PNS - Google Patents

New use of substance in PNS

Info

Publication number
SE9901578D0
SE9901578D0 SE9901578A SE9901578A SE9901578D0 SE 9901578 D0 SE9901578 D0 SE 9901578D0 SE 9901578 A SE9901578 A SE 9901578A SE 9901578 A SE9901578 A SE 9901578A SE 9901578 D0 SE9901578 D0 SE 9901578D0
Authority
SE
Sweden
Prior art keywords
cck
peripheral
substance
activity
nervous system
Prior art date
Application number
SE9901578A
Other languages
Swedish (sv)
Inventor
Thomas Lundeberg
Paola Tirassa
Luigi Manni
Luigi Aloe
Original Assignee
Karolinska Innovations Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Karolinska Innovations Ab filed Critical Karolinska Innovations Ab
Priority to SE9901578A priority Critical patent/SE9901578D0/en
Publication of SE9901578D0 publication Critical patent/SE9901578D0/en
Priority to CN00808285A priority patent/CN1353616A/en
Priority to EP00925847A priority patent/EP1173196A1/en
Priority to RU2001132588/14A priority patent/RU2001132588A/en
Priority to PCT/SE2000/000870 priority patent/WO2000066150A1/en
Priority to AU44474/00A priority patent/AU4447400A/en
Priority to JP2000615034A priority patent/JP2003509336A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2207—Gastrins; Cholecystokinins [CCK]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Abstract

Peripheral neuropathies include disorders in structure and function of peripheral motor and sensory neurons, and can involve the entire neuron as well as part of it. Exogenous administration of CCK-8 and analogues thereof has been shown to induce the cellular production of neurotrophic factors, especially NGF, which can treat neuropathic states in the peripheral nervous system. Accordingly, the present invention relates to the use of a substance showing CCK-8 activity for the treatment of neuropathies in the peripheral nervous system, as well as a pharmaceutical composition comprising a substance showing CCK-8 activity.
SE9901578A 1999-05-03 1999-05-03 New use of substance in PNS SE9901578D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SE9901578A SE9901578D0 (en) 1999-05-03 1999-05-03 New use of substance in PNS
CN00808285A CN1353616A (en) 1999-05-03 2000-05-03 New use of substance in PNS
EP00925847A EP1173196A1 (en) 1999-05-03 2000-05-03 New use of a substance in pns
RU2001132588/14A RU2001132588A (en) 1999-05-03 2000-05-03 New Use of Substances for PMS
PCT/SE2000/000870 WO2000066150A1 (en) 1999-05-03 2000-05-03 New use of a substance in pns
AU44474/00A AU4447400A (en) 1999-05-03 2000-05-03 New use of a substance in pns
JP2000615034A JP2003509336A (en) 1999-05-03 2000-05-03 New use of substances in PNS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9901578A SE9901578D0 (en) 1999-05-03 1999-05-03 New use of substance in PNS

Publications (1)

Publication Number Publication Date
SE9901578D0 true SE9901578D0 (en) 1999-05-03

Family

ID=20415431

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9901578A SE9901578D0 (en) 1999-05-03 1999-05-03 New use of substance in PNS

Country Status (7)

Country Link
EP (1) EP1173196A1 (en)
JP (1) JP2003509336A (en)
CN (1) CN1353616A (en)
AU (1) AU4447400A (en)
RU (1) RU2001132588A (en)
SE (1) SE9901578D0 (en)
WO (1) WO2000066150A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003047612A1 (en) * 2001-12-03 2003-06-12 Thomas Lundeberg The use of cck-8 for the preparation of a pharmaceutical composition against inflammatory disorders
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1204430B (en) * 1986-01-10 1989-03-01 Alfio Bertolini PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES OF THE COLECISTOKININA-CERULINA GROUP FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULATORY INSUFFICIENCY

Also Published As

Publication number Publication date
CN1353616A (en) 2002-06-12
EP1173196A1 (en) 2002-01-23
RU2001132588A (en) 2003-08-10
AU4447400A (en) 2000-11-17
WO2000066150A1 (en) 2000-11-09
JP2003509336A (en) 2003-03-11

Similar Documents

Publication Publication Date Title
ATE253932T1 (en) USE OF ERYTHROPOIETIN OR ERYTHROPOIETIN DERIVATIVES FOR THE TREATMENT OF CEREBRAL ISCHEMIA
WO2005063297A3 (en) Melatonin combination therapy for improving sleep quality
JO2373B1 (en) W-Carboxyaryl Substituted Diphenyl Ureas As Raf Kinease Inhibitors
NO20061325L (en) Combination of drugs for the treatment of neoplasms
EP1140840A4 (en) -g(v)-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
ATE411813T1 (en) BOTULINUM TOXIN TREATMENTS OF NEUROLOGICAL AND NEUROPSYCHIATRIC DISEASES
ATE299022T1 (en) USE OF CYCLOPAMINE IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PSORIASIS
ID26956A (en) PREVENTION OF RAF KINASE USING SYMBETRIS AND NONSymmetry REPLACED BY UREA
EA200701296A1 (en) 3,5-Disposable and 3,5,7-triple-substituted 3H-oxazolo-and 3H-thiazolo [4,5-D] pyrimidin-2-she and their medicines
ES2178668T4 (en) NAFTILAMIDS AS AGENTS OF THE CENTRAL NERVOUS SYSTEM.
WO2003092617A3 (en) Combinations for the treatment of inflammatory skin disorders
ATE245452T1 (en) HYALURONATE LYASE AS A PENETRATION PROMOTER IN TOPICAL AGENTS
DK1032556T3 (en) Pharmaceutically active compounds and methods of use
SE9901578D0 (en) New use of substance in PNS
TW200510437A (en) Phosphinane compound with immunomodulating activity
WO2000061125A3 (en) Osanetant in the treatment of mood disorders
PL376368A1 (en) 4-aminopiperidine derivatives, processes for their preparation and their use as medicaments
ATE398134T1 (en) NEW ANALOGUE OF NITROBENZYLTHIOINOSINE
DE60306503D1 (en) STATIN THERAPY FOR IMPROVING THE MAINTENANCE OF COGNITIVE FUNCTION
ES2144857T3 (en) USE OF BENZONAPHTHALENIC DERIVATIVES FOR THE MANUFACTURE OF MEDICINES INTENDED FOR THE TREATMENT OF DISEASES OF THE NERVOUS SYSTEM.
WO2008100450A3 (en) Therapeutic effects of bryostatins, bryologs, and other related substances on ischemia/stroke-induced memory impairment and brain injury
ATE374202T1 (en) NEW ANALOGUE OF NITROBENZYLTHIOINOSINE
DE60004093D1 (en) PHARMACEUTICAL COMPOSITION WHICH CONTAINS RILUZOL AND GABAPENTIN FOR THE TREATMENT OF MOTONEURONAL DISEASES
WO2001093889A3 (en) Vip-related peptides for the treatment of skin disorders
ATE201993T1 (en) USE OF OLNZAPINE IN THE PRODUCTION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF CEREBRAL FOCAL ISCHEMIA